PRADAXA 75 MG CAPSULE

dabigatran etexilate mesylate
$3.1632per EA

Strength

75 mg/1

NDC

00597035509

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA022512

On Market Since

8/8/2011

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

+0.1%

3M

-0.1%

6M

-0.1%

1Y

-0.2%

3Y

-60.2%

5Y

-58.6%

All

-50.7%

Related Drugs

Same classification

No related drugs found.